Paul Negulescu
Paul Negulescu | |
|---|---|
| Born | Paul Adrian Negulescu |
| Education | University of California, Berkeley (BSc, PhD) |
| Known for | Research of cystic fibrosis |
| Awards | Warren Alpert Foundation Prize (2018) Shaw Prize in Life Science & Medicine (2022) Wiley Prize (2023) Breakthrough Prize in Life Sciences (2024) |
| Scientific career | |
| Fields | Cell biology |
| Institutions | University of California, Irvine Aurora Biosciences Vertex Pharmaceuticals |
| Thesis | The role and regulation of intracellular calcium during stimulus-secretion coupling in the parietal cell (1988) |
| Doctoral advisor | Terry Machen |
Paul Adrian Negulescu is an American–Romanian cell biologist. He is a Senior Vice President at American pharmaceutical company Vertex Pharmaceuticals. He received the 2022 Shaw Prize in Life science and medicine, together with Michael J. Welsh, for their work that uncovered the etiology of cystic fibrosis and developed effective medications.